Apply Now for the AIM-HI Women-Led Oncology Venture Competition 2026

Application Deadline: March 15, 2026

The AIM-HI Women-Led Oncology Venture Competition 2026 is now accepting applications from women scientist-entrepreneurs who are leading groundbreaking innovations in the fight against cancer. This global initiative by the AIM-HI Accelerator Fund provides women-led oncology companies with early-stage investment opportunities, expert mentoring, and access to an extensive network of investors and industry leaders.

Empowering Women Innovators in Cancer Research

The AIM-HI Women-Led Oncology Venture Competition is designed to support and accelerate the growth of women-founded or women-led oncology ventures across the globe. The program aims to bridge the gender gap in life sciences by providing financial backing, coaching, and visibility to female scientists driving change in cancer research and treatment innovation.

This initiative supports oncology companies at the pre-seed, seed, and Series A investment stages. It emphasizes technology ownership, leadership development, mentoring, and global networking — helping women founders strengthen their ventures and scale their impact in the oncology space.

Who Can Apply

The competition is open to women-led oncology startups and companies worldwide seeking early-stage investments. To qualify, each company must have:

• A woman in senior leadership (Founder or C-level executive) holding an equity stake.
• Ownership of proprietary oncology technology or intellectual property.

These eligibility criteria ensure that supported businesses are genuinely led by women scientists and innovators committed to advancing cancer treatment.

What Selected Participants Gain

Beyond funding, participants gain access to a unique ecosystem of support. The program connects them with a selection and judging committee composed of global oncology leaders, scientists, investors, and industry mentors. These experts provide valuable feedback on business models, research strategies, clinical development, and intellectual property positioning.

Top winners of the competition receive:

• Honorariums and certificates of recognition
• Global exposure within the oncology research community
• Investment consideration from AIM-HI and co-investors following a rigorous due diligence process

Successful companies that pass the due diligence stage become eligible for investment from the AIM-HI Accelerator Fund and its partners, enabling them to further advance their cancer-fighting innovations.

Why This Competition Matters

The AIM-HI Women-Led Oncology Venture Competition represents more than just funding — it’s a movement to ensure that women scientists are visible, supported, and empowered to lead in cancer innovation. By combining investment with mentorship, visibility, and leadership development, the program ensures that women entrepreneurs can overcome systemic barriers and bring their life-saving technologies to market faster.

In a field as critical as oncology, where innovation can literally save lives, empowering women-led ventures drives progress and diversity in research. It also strengthens global collaboration between scientists, investors, and innovators united by the goal of defeating cancer.

Mentorship, Leadership, and Global Collaboration

AIM-HI’s investment model is built on partnership and mentorship. Each participating company gains access to expert guidance from professionals experienced in drug development, regulatory strategy, and biotech commercialization. The program also helps refine participants’ intellectual property frameworks, clinical pathways, and commercialization plans.

Additionally, AIM-HI provides visibility and strategic networking opportunities within its global ecosystem of life science investors, entrepreneurs, and influencers. These connections open doors to potential co-investments, joint ventures, and international collaborations that accelerate company growth.

Application Details

• Organizer: AIM-HI Accelerator Fund
• Program Type: Venture Competition
• Post Date: January 2, 2026
• Deadline: March 15, 2026
• Focus Areas: Women in STEM, Oncology Innovation, Entrepreneurship, Leadership Development
• Eligible Applicants: Women-led oncology companies worldwide

A Global Platform for Women Transforming Cancer Innovation

Over the years, AIM-HI has championed women’s leadership in oncology innovation, helping bring promising cancer therapies from concept to clinic. This competition continues that mission by offering both financial and non-financial support to female scientists ready to scale their discoveries into impactful ventures.

By joining this competition, women entrepreneurs not only access vital funding but also become part of a global movement redefining cancer innovation. Each selected venture contributes to advancing equitable representation, scientific excellence, and improved health outcomes worldwide.

If you are a woman scientist leading an oncology startup with breakthrough technology, the AIM-HI Women-Led Oncology Venture Competition 2026 offers the opportunity to elevate your innovation, gain mentorship from global experts, and access the funding needed to make a lasting impact in the fight against cancer.

For more information and to apply, CLICK HERE

Be one of the first to see new opportunities, Follow Us on social media: Facebook, Whatsapp group, LinkedIn and Whatsapp Channel